PMC3970253_01
T2 brain MRI one day ((a), (c)) and seven days ((b), (d)) after admission. Signal abnormalities in bilateral thalami ((a), arrows) and interval improvement (b). Signal abnormalities involving the hypothalamus ((c), white arrows), periaqueductal gray matter ((c), black arrows), and interval improvement (d).
CRINM2014-430729.001.jpg
PMC3970253_01_CRINM2014-430729.001.jpg
fig1
On admission day 2, the neurological team ordered a follow-up brain MRI, which showed signal abnormalities involving the hypothalamus, periaqueductal gray matter, and bilateral thalami (Figures 1(a), 1(c), 2(a), 2(c), and 3(a)). A repeat MRI on the 7th day of admission showed marked resolution in the abnormal signals (Figures 1(b), 1(d), 2(b), 2(d), and 3(b)).
Corresponding FLAIR MRIs one day ((a), (c)) and seven days ((b), (d)) after admission. Signal abnormalities in bilateral thalami (a) and interval improvement (b). Signal abnormalities involving the hypothalamus (c), periaqueductal gray matter (c), and interval improvement (d).
CRINM2014-430729.002.jpg
PMC3970253_01_CRINM2014-430729.002.jpg
fig2
On admission day 2, the neurological team ordered a follow-up brain MRI, which showed signal abnormalities involving the hypothalamus, periaqueductal gray matter, and bilateral thalami (Figures 1(a), 1(c), 2(a), 2(c), and 3(a)). A repeat MRI on the 7th day of admission showed marked resolution in the abnormal signals (Figures 1(b), 1(d), 2(b), 2(d), and 3(b)).